Side-by-side comparison

CompareIsomorphic LabsvsRecursion

Compare tools

2 of 4 tools selected

AI Drug Discovery & Molecule Design Software

Isomorphic Labs

DeepMind spinout for AI drug design

SF Score
8.4/10
Pricing
Contact sales
AI Drug Discovery & Molecule Design Software

Recursion

AI biotech with cellular imaging and automation

SF Score
8.1/10
Pricing
Contact sales
Add third toolCompare up to 4 side by side

Compare features, strengths, trade-offs, and best-fit use cases.

Where each one leads

Read straight from the published figures below — not a ranking, and not a recommendation.

  • Highest SF Score

    Isomorphic Labs8.4/10

    2 of 2 are scored

At a glance

The short version

The facts each tool publishes, lined up so you can scan down a column. Anything the catalog does not establish is marked as such rather than counted against the tool.

Isomorphic Labs

SF Score
8.4 / 10
Free plan
Not offered
Category
AI Healthcare & Medical Software › AI Drug Discovery & Molecule Design Software

Recursion

SF Score
8.1 / 10
Free plan
Not offered
Category
AI Healthcare & Medical Software › AI Drug Discovery & Molecule Design Software

Key differences

Where these tools actually diverge

The decision dimensions that separate this set, with each tool's own position stated plainly. No winner is declared — fit depends on your workflow.

Positioned for

Isomorphic Labs

AI Drug Discovery & Molecule Design Software

Recursion

AI Drug Discovery & Molecule Design Software

Pricing model

Isomorphic Labs

Contact sales

Recursion

Contact sales

SoftFinders Score

Isomorphic Labs

8.4 / 10

Recursion

8.1 / 10

Feature comparison

Capability matrix

Grouped by area. Every state carries a word as well as a colour, and anything the catalog has not established stays neutral rather than counting as a missing feature.

1 row differs 8 identical

Capability comparison across the selected tools. Each row is a capability; each column is a tool.
Capability Isomorphic LabsRecursion
Overview
SF Score8.4 / 10Value8.1 / 10Value
Pricing modelCustomValueCustomValue
Free planNoNo
CategoryAI Healthcare & Medical Software › AI Drug Discovery & Molecule Design SoftwareValueAI Healthcare & Medical Software › AI Drug Discovery & Molecule Design SoftwareValue
Core features
Virtual ScreeningScreens compound libraries against targetsYesYes
Literature IntelligenceMines biomedical literature for relevant evidenceYesYes
Multi OmicsIntegrates genomic and other omics data sourcesYesYes
Partner WorkflowsWorkflows for pharma partner collaborationsYesYes
Integrations
Lab IntegrationConnects discovery insights with wet-lab workflowsYesYes

Scroll the matrix sideways to see every column.

Listed by one tool only

2 capabilities are published by a single tool in this set. That does not mean the others lack them — only that the catalog has not established an answer either way.

Use cases

What each tool is built for

The workflows each tool publishes for itself. Cards appear only for tools that list use cases.

Isomorphic Labs

  • Mine literature for research signals
  • Run virtual screens against targets
  • Collaborate with pharma partners
  • Bridge AI design and wet lab cycles
  • Identify drug targets from biology data

+1 more on the Isomorphic Labs profile

Recursion

  • Run virtual screens against targets
  • Collaborate with pharma partners
  • Bridge AI design and wet-lab cycles
  • Identify drug targets from biology data
  • Accelerate molecule design cycles

+1 more on the Recursion profile

Pros & cons

Strengths and compromises

Each tool's published strengths and the compromises that come with them, as supplied — not scored or ranked against each other. Longer lists fold; nothing is left out.

Isomorphic Labs

Pros

  • Frontier AI models for protein and molecule design
  • Strong pharma partnership track record
  • Linked to DeepMind's research depth

Cons

  • Not available as self-serve software today
  • Engagement relies heavily on partnership exclusivity
  • Public access to platform tools is limited

Recursion

Pros

  • Phenomics platform with extensive multimodal data
  • Active pharma collaborations and internal pipeline
  • Public company with transparent disclosures

Cons

  • Direct buyer access remains limited to partnerships
  • Drug development cycles can take many years
  • Recursion's brand is evolving through Exscientia integration

Pricing

What each one costs

Published pricing signals only. Where a tool has not established a price, that is what it says — never a zero and never "free".

Next step

Ready to try one?

A matrix narrows the field; a free trial settles it. Open whichever tool fits your workflow best, or start a different comparison.

Compare another set of tools